Abstract
Introduction
Diabetes mellitus is the amongst the largest health emergencies of the 21 st There is a complex cause effect relationship between hypertension and diabetes mellitus which is hypothesised. The new onset diabetes mellitus in hypertensive patients could be caused by treatment with antihypertensive drugs such as diuretics and beta blockers (3) . Both diabetes mellitus and hypertension are manageable health conditions which can be controlled through use of medicines, exercise and diet. The detection of progenitors namely pre-diabetes and prehypertension by surveillance enables the early intervention and result in delay in the disease progression (2) . The World Health Organisation does recommend cardiovascular risk century causing life changing complications. Africa is reported to have the largest proportion of undiagnosed diabetes mellitus, it is estimated over two thirds of the people with diabetes mellitus are unaware of it(1). Diabetes mellitus and hypertension coexist in patients. The prevalence of hypertension is reported to be 1.5 to 2.0 times more in diabetes mellitus patients compared to non-diabetics whilst approximately a third of hypertension patients would develop diabetes mellitus. The coexistence of the two results in an increased risk and can accelerate vascular complications (2) . assessment which does include glucose testing amongst patients presenting with hypertension (4) . A third of all people with diabetes mellitus are reported that they may be undiagnosed and above 60% of the newly diagnosed diabetes mellitus patients are unaware of their condition until they develop complications (5) .
There is paucity of documented data on prevalence of undiagnosed diabetes mellitus in high risk groups such as hypertensive patients in a clinical setting in Zimbabwe. Thus the study sought to determine the prevalence of undiagnosed diabetes mellitus in hypertensive patients attending an outpatient clinic in Harare, Zimbabwe.
Methods

Ethical considerations
The study was approved by the Joint Research Ethics Committee of the Parirenyatwa Group of Hospitals and University of Zimbabwe College of Health Sciences (JREC 342/15) and informed consent was obtained for all the study participants included in the study.
Study design and study sites
A cross-sectional study was carried out on hypertensive patients attending Parirenyatwa Group of Hospitals Outpatient Clinic, Harare, Zimbabwe in the period 08 February 2016 to 21 March 2016.ParirenyatwaGroup of Hospitals is at tertiary teaching hospital located in the capital city of Zimbabwe Harare.
Study subjects
All adult hypertensive patients (18 years and above) attending Parirenyatwa Group of Hospitals Outpatient Clinic were given information on study. All hypertensive patients who were not diagnosed of diabetes mellitus before who consented to participate in the study were consecutively enrolled.
Data collection
A questionnaire was administered on all adult hypertensive patients who consented to participate in study. A blood sample was collected into an ethylenediaminetetra acetic acid (EDTA) tube for glycosylated haemoglobin analysis(HbA1c) using vacuitaner method of blood collection.
Sample analysis
The samples collected in EDTA tubes were stored at 2 to 8 degrees Celsius and analysed for HbA1c within a week. The samples were thawed to room temperature and glycosyslated haemoglobin analysis was carried outon a Mindray BS 800 Chemistry Analyser(Mindray, Shenzhen, China). The assay kits, calibrators and standards were supplied by the manufacturer. The analyser was calibrated and then controls were assayed before the samples were analysed following manufacturers' recommendations.
Data analysis
Statistical Package for the Social Sciences version 8 data analysis package was used to analyse the data. Normally distributed data was analysed using mean and standard deviation. Normally distributed data was compared using the student t test.
Definitions
The following case definitions were used:
• Non-diabetes, HbA1c < 6.0 % (6)(7) • Pre-diabetes, HbA1c between 6.0% and 6.4% (6)(7) • Diabetes mellitus, HbA1c ≥ 6.5% (6)(7)
Results
One hundred and four hypertensive patients were recruited into the study of whom 64.4% (67) were female. The mean age of study participants was 60.91(± standard deviation of 14.06) years. 76.0% (79) of participants were on enalapril and 24.0% (25) were on atenolol antihypertensive drugs. The mean HbA1c was 5.8%. There was no significant difference in mean HbAIc levels of females (5.7%) and male (5.9%) participants, (p value = 0.335).
Patients with the duration of hypertension greater than 10 years constituted 34% (35) of the study population and 81% (84) of participants had no family history of diabetes mellitus. Eighty six percent (89) of the study participants reported that they do not undertake regular exercise. Table 1 shows the prevalence of undiagnosed diabetes mellitus was 22.1% (23). Among diabetic hypertensive participants were 56.5% (13) females and 43.5% (10) males. Prediabetes constituted 26% (27) of participants with 66.7% (18) being females and 33.3% (9) were males. 51.9% (54) of study participants were non-diabetic and of these 66.7% (36) were females while 33.3% (18) were males.
Discussion
The coexistence of hypertension and diabetes mellitus does increase the risk of end organ damage, the incidences of cardiovascular disease and mortality. Whilst pre-diabetes is an independent risk factor for incident cardiovascular disease and mortality (8) . Pre-diabetes is an intermittent stage of overt diabetes where blood glucose is higher than normal value but not high enough to meet diagnostic criteria of diabetes mellitus. The majority of diabetes mellitus patients are reported to go through a pre-diabetes phase for several years in which an opportunity exist to identify them and commence timely prevention. Studies have reported that the use of HbA1c is a highly standardised convenient test which exhibits low intraindividual variation which can be obtained at any time requiring no patient preparation and a sample is relatively stable at room temperature after collection. A strong correlation exists between average plasma glucose and HbA1c (5) which we used in this current study.
In this current study the prevalence of pre-diabetes mellitus was 26.0% whilst that of diabetes mellitus was 22.1%. A study at a district hospital in Kiambu Kenya [2014] reported prevalence of pre-diabetes of 18% and 14% newly diagnosed diabetes mellitus(5). In as study at Mulago hospital in Uganda [2005] [2006] prevalence of pre-diabetes mellitus was 50% and newly diagnosed diabetes mellitus was 24% (9) .A study at a tertiary hospital in Imo state of Nigeria [2011] reported a prevalence of pre-diabetes of 33.1% amongst adult Nigerians with essential hypertension (10) .
In Germany amongst hypertensive patients they reported prevalence of pre-diabetes of 39% and diabetes mellitus of 12% (11) . Lower prevalence of pre-diabetes and diabetes mellitus are expected in developed countries due to their better glucose testing programmes. Whilst on the contrary higher rates of pre-diabetes and diabetes in developing countries are due to lack of rigorous screening which leaves many patients undiagnosed (9) . Above three quarters of the patients were on enalapril an angiotensin converting enzyme inhibitor which is amongst the second line antihypertensive agents in Zimbabwe whilst the rest were on atenolol a beta blocker which is amongst the first line antihypertensive agents in Zimbabwe (12) . Beta blockers have been associated with new onset diabetes amongst hypertension patients (3).
Eighty nine percent of patients reported that they do not undertake regular exercise which however has been reported that if it is combined with dietary intervention decrease incidence of type 2 diabetes mellitus in high risk group (13) .
We recommend regular screening of diabetes mellitus amongst the hypertensive patients to diagnose pre-diabetes mellitus and prevent the development of diabetes mellitus which is associated with morbidity and mortality.
Conclusion
The prevalence of undiagnosed diabetes mellitus was found to be 22, 1% among hypertensive patients which is higher than that reported in Kenya but lower than that reported in Uganda. Diabetes mellitus can be highly prevalent in hypertensive patients thus there is need for constant monitoring for the development of diabetes mellitus and further research using a national representative sample.
